ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is making significant strides in the healthcare sector, particularly within the biotechnology industry. With a focus on developing and commercializing treatments for central nervous system..
For investors eyeing the healthcare sector, Protagonist Therapeutics, Inc. (PTGX) presents an intriguing opportunity within the biotechnology industry. With a market capitalization of $5.19 billion, the company is making notable..
Sotera Health Company (NASDAQ: SHC), a key player in the healthcare diagnostics and research industry, has captured significant attention from investors due to its robust market positioning and promising financial..
DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specializes in dental and medical instruments. Despite facing a challenging financial landscape, the company continues to draw investor..
CRISPR Therapeutics AG (NASDAQ: CRSP), a Swiss-based biotechnology firm, is at the forefront of gene editing technology with its innovative CRISPR/Cas9 platform. The company’s focus on developing gene-based medicines for..
Investors with an interest in the biotechnology sector may find Merus N.V. (MRUS) an intriguing consideration, as the company offers a mix of opportunity and challenges, highlighted by its 7.78%..
Investors eyeing the biotechnology sector may find Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) an intriguing prospect due to its focus on rare and ultra-rare genetic diseases. Headquartered in Novato, California, this..
Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company headquartered in New York City, is making waves within the healthcare plans industry. With a market capitalization of $4.13 billion, Oscar..
In the dynamic realm of biotechnology, ADMA Biologics Inc (NASDAQ: ADMA) has carved out a niche with its specialty plasma-derived biologics, targeting immune deficiencies and infectious diseases. With a market..
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a significant player in the biotechnology sector, specifically focusing on the discovery and development of RNA-targeted therapeutics and gene therapies for rare diseases...
Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves in the healthcare sector with its innovative approach to tackling obstructive sleep apnea (OSA). With a market capitalization of $2.24 billion,..
Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, focuses on designing and manufacturing single-use medical products critical for interventional, diagnostic, and therapeutic procedures. With a..
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing the attention of investors with its remarkable upside potential. As a clinical-stage biopharmaceutical company, Soleno is focused on developing innovative treatments for rare..
Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology space, has been catching the eye of investors with its innovative approach in diagnostics and research. With a market..
Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, specializes in medical instruments and supplies with a particular focus on women’s health. With a market capitalization of $16.73..
Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, is currently drawing attention from investors due to its potential upside of 19.37%, according to analyst ratings. As a..
Akero Therapeutics, Inc. (NASDAQ: AKRO) has emerged as a prominent player in the biotechnology sector, focusing on developing innovative treatments for serious metabolic diseases. With a market capitalization of $4.5..
Avidity Biosciences, Inc. (NASDAQ: RNA) stands at the forefront of a revolutionary approach in biotechnology, leveraging its proprietary antibody oligonucleotide conjugates (AOCs) platform to address previously untreatable diseases. As a..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is gaining attention from investors with its promising potential upside of 38.09%. This commercial-stage biopharmaceutical company, headquartered in Boston, is pioneering treatments for rare neuroendocrine..
